Annual report pursuant to Section 13 and 15(d)

Segment Reporting - Segment Reporting Financial Information (Details)

v3.22.0.1
Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]    
Revenues $ 80,859,653 $ 58,682,976
Depreciation and amortization 6,088,947 2,734,462
Segment operating income 5,352,419 5,492,130
Bargain purchase gain 0 0
Other expense, net (69,878) (79,478)
Income before income tax expense 5,282,541 5,412,652
Segment operating income:    
Segment Reporting Information [Line Items]    
Segment operating income 21,139,515 17,070,268
Unallocated corporate    
Segment Reporting Information [Line Items]    
Segment operating income (15,787,096) (11,578,138)
Corporate clinics    
Segment Reporting Information [Line Items]    
Revenues 44,348,234 31,757,207
Depreciation and amortization 5,446,663 2,503,181
Corporate clinics | Segment operating income:    
Segment Reporting Information [Line Items]    
Segment operating income 4,432,872 4,508,990
Franchise operations    
Segment Reporting Information [Line Items]    
Revenues 36,511,419 26,925,769
Depreciation and amortization 334,945 0
Franchise operations | Segment operating income:    
Segment Reporting Information [Line Items]    
Segment operating income 16,706,643 12,561,278
Corporate administration    
Segment Reporting Information [Line Items]    
Depreciation and amortization $ 307,339 $ 231,281